A Phase 2 Study of Abemaciclib in Recurrent Glioblastoma
Latest Information Update: 22 Jul 2024
At a glance
- Drugs Abemaciclib (Primary)
- Indications Astrocytoma; Glioblastoma
- Focus Pharmacokinetics; Therapeutic Use
- 16 Jul 2024 Planned End Date changed from 1 Jun 2025 to 30 Jun 2025.
- 24 Jul 2023 Planned End Date changed from 1 Jun 2024 to 1 Jun 2025.
- 24 Jul 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Jun 2024.